| A review of the global burden, new diagnostics, and current therapeutics for amebiasis DAT Shirley, L Farr, K Watanabe, S Moonah Open forum infectious diseases 5 (7), ofy161, 2018 | 341 | 2018 |
| Role of MIF cytokine/CD74 receptor pathway in protecting against injury and promoting repair L Farr, S Ghosh, S Moonah Frontiers in Immunology 11, 1273, 2020 | 109 | 2020 |
| CD74 signaling links inflammation to intestinal epithelial cell regeneration and promotes mucosal healing L Farr, S Ghosh, N Jiang, K Watanabe, M Parlak, R Bucala, S Moonah Cellular and molecular gastroenterology and hepatology 10 (1), 101-112, 2020 | 44 | 2020 |
| Parasite-produced MIF cytokine: role in immune evasion, invasion, and pathogenesis S Ghosh, N Jiang, L Farr, R Ngobeni, S Moonah Frontiers in immunology 10, 1995, 2019 | 39 | 2019 |
| Entamoeba histolytica–Encoded Homolog of Macrophage Migration Inhibitory Factor Contributes to Mucosal Inflammation during Amebic Colitis R Ngobeni, MM Abhyankar, NM Jiang, LA Farr, A Samie, R Haque, ... The Journal of infectious diseases 215 (8), 1294-1302, 2017 | 31 | 2017 |
| COP9 signalosome is an essential and druggable parasite target that regulates protein degradation S Ghosh, L Farr, A Singh, LA Leaton, J Padalia, DA Shirley, D Sullivan, ... PLoS pathogens 16 (9), e1008952, 2020 | 25 | 2020 |
| Interaction between parasite-encoded JAB1/CSN5 and macrophage migration inhibitory factor proteins attenuates its proinflammatory function S Ghosh, LA Leaton, L Farr, A Barfield, S Moonah Scientific reports 8 (1), 10241, 2018 | 15 | 2018 |
| Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy MM Abhyankar, MT Orr, R Kinsey, S Sivananthan, AJ Nafziger, ... Frontiers in Immunology 12, 683157, 2021 | 12 | 2021 |
| Targeting Parasite-Produced Macrophage Migration Inhibitory Factor as an Antivirulence Strategy With Antibiotic–Antibody Combination to Reduce Tissue Damage S Ghosh, J Padalia, R Ngobeni, J Abendroth, L Farr, DA Shirley, ... The Journal of infectious diseases 221 (7), 1185-1193, 2020 | 10 | 2020 |
| Infection and inflammation stimulate expansion of a CD74+ Paneth cell subset to regulate disease progression I Balasubramanian, S Bandyopadhyay, J Flores, J Bianchi‐Smak, X Lin, ... The EMBO Journal, e113975, 2023 | 2 | 2023 |
| Purification of Antibodies Against Entamoeba histolytica MIF and Their Use in Analyzing Human and Mouse Samples L Farr, K Watanabe, S Moonah Macrophage Migration Inhibitory Factor: Methods and Protocols, 237-247, 2020 | 2 | 2020 |
| Alcohol Abuse Drug Disulfiram Is Effective against Cyst Stages of Entamoeba histolytica Parasite I Sharma, L Farr, S Moonah Antimicrobial Agents and Chemotherapy 66 (11), e00832-22, 2022 | | 2022 |
| Optimizing a Multi-Component MM Abhyankar, MT Orr, R Kinsey, S Sivananthan, AJ Nafziger, ... Mucosal Vaccination: Strategies to Induce and Evaluate Mucosal Immunity, 2022 | | 2022 |
| Tu1233 REPAIR RECEPTOR CD74 IS NECESSARY FOR ANTI-TNF TREATMENT RESPONSE LA Farr, S Moonah Gastroenterology 158 (6), S-1028, 2020 | | 2020 |
| New parasite treatment with old alcohol drug targeting COP9 signalosome S Ghosh, L Farr, A Singh, LA Leaton, J Padalia, DJ Sullivan, SN Moonah The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| 830 Can CD74 Predict Treatment Response to Anti-TNF Agents in Inflammatory Bowel Disease? L Farr, R Bucala, S Moonah Official journal of the American College of Gastroenterology| ACG 114, S480, 2019 | | 2019 |
